Reply to: "Comment on 'Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes'"

Luca Schneller-Pavelescu; Eduardo Vergara-de Caso; Antonio Martorell; Jorge Romaní; Mireya Lázaro; Eva Vilarrasa; Blanca Díaz-Ley; Igor Vázquez-Osorio; Juan Manuel Segura Palacios; José Manuel Azaña; Marcos Antonio González-López; Javier Cañueto; Alejandro Molina-Leyva; María Leiva-Salinas; Francisco José Navarro-Triviño; José Sánchez-Payá; José C Pascual

doi:10.1016/j.jaad.2019.03.006

Reply to: "Comment on 'Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes'"

J Am Acad Dermatol. 2023 May;88(5):e271-e272. doi: 10.1016/j.jaad.2019.03.006. Epub 2019 Mar 11.

Authors

Luca Schneller-Pavelescu¹, Eduardo Vergara-de Caso², Antonio Martorell³, Jorge Romaní⁴, Mireya Lázaro⁵, Eva Vilarrasa⁶, Blanca Díaz-Ley⁷, Igor Vázquez-Osorio⁸, Juan Manuel Segura Palacios⁹, José Manuel Azaña¹⁰, Marcos Antonio González-López¹¹, Javier Cañueto¹², Alejandro Molina-Leyva¹³, María Leiva-Salinas¹⁴, Francisco José Navarro-Triviño¹⁵, José Sánchez-Payá¹⁶, José C Pascual²

Affiliations

¹ Department of Dermatology, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL-FISABIO Foundation), Alicante, Spain. Electronic address: lucapavelescu@gmail.com.
² Department of Dermatology, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL-FISABIO Foundation), Alicante, Spain.
³ Department of Dermatology, Hospital de Manises, Valencia, Spain.
⁴ Department of Dermatology, Corporació Sanitaria Parc Taulí, Sabadell, Spain.
⁵ Department of Dermatology, Hospital de Basurto, Bilbao (Vizcaya), Spain.
⁶ Department of Dermatology, Hospital de la Santa Creui Sant Pau, Barcelona, Spain.
⁷ Department of Dermatology, Hospital del Sureste, Arganda del Rey, Spain.
⁸ Department of Dermatology, Hospital de Cabueñes, Gijón, Spain.
⁹ Department of Dermatology, Hospital Costa del Sol, Marbella, Spain.
¹⁰ Department of Dermatology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
¹¹ Department of Dermatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
¹² Department of Dermatology, Hospital Clínico Universitario de Salamanca, Salamanca, Spain.
¹³ Department of Dermatology, Hospital Universitario Virgen de las Nieves, Granada, Spain.
¹⁴ Department of Dermatology, Hospital Marina Baixa, Villajoyosa, Spain.
¹⁵ Department of Dermatology, Hospital Comarcal Santa Ana, Motril, Spain.
¹⁶ Epidemiology Unit, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL-FISABIO Foundation), Alicante, Spain.

PMID: 30872153
DOI: 10.1016/j.jaad.2019.03.006

No abstract available

Publication types

Observational Study
Letter
Comment

MeSH terms

Anti-Bacterial Agents / therapeutic use
Clindamycin* / adverse effects
Hidradenitis Suppurativa* / chemically induced
Hidradenitis Suppurativa* / drug therapy
Humans
Prevalence
Rifampin / therapeutic use

Substances

Clindamycin
Rifampin
Anti-Bacterial Agents